Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00301834
Status:
COMPLETED
Last Update Posted:
2017-09-28
First Post:
2006-03-09
Brief Title:
Alemtuzumab Fludarabine and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
Sponsor:
Organization:
University of California San Francisco